Ad is loading...
BEAM
Price
$24.05
Change
-$2.26 (-8.59%)
Updated
Nov 15 closing price
106 days until earnings call
BLUE
Price
$0.32
Change
-$0.04 (-11.11%)
Updated
Nov 15 closing price
99 days until earnings call
Ad is loading...

BEAM vs BLUE

Header iconBEAM vs BLUE Comparison
Open Charts BEAM vs BLUEBanner chart's image
Beam Therapeutics
Price$24.05
Change-$2.26 (-8.59%)
Volume$2.26M
CapitalizationN/A
bluebird bio
Price$0.32
Change-$0.04 (-11.11%)
Volume$9.16M
CapitalizationN/A
BEAM vs BLUE Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. BLUE commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongSell and BLUE is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BEAM: $24.05 vs. BLUE: $0.32)
Brand notoriety: BEAM and BLUE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 218% vs. BLUE: 150%
Market capitalization -- BEAM: $1.99B vs. BLUE: $62.21M
BEAM [@Biotechnology] is valued at $1.99B. BLUE’s [@Biotechnology] market capitalization is $62.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileBLUE’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • BLUE’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and BLUE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while BLUE’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • BLUE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BLUE is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -11.12% price change this week, while BLUE (@Biotechnology) price change was -20.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

BLUE is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.99B) has a higher market cap than BLUE($62.2M). BEAM YTD gains are higher at: -11.646 vs. BLUE (-76.754). BLUE has higher annual earnings (EBITDA): -131.77M vs. BEAM (-162.88M). BEAM has more cash in the bank: 1.01B vs. BLUE (3.77M). BEAM has less debt than BLUE: BEAM (165M) vs BLUE (304M). BEAM has higher revenues than BLUE: BEAM (353M) vs BLUE (21.7M).
BEAMBLUEBEAM / BLUE
Capitalization1.99B62.2M3,201%
EBITDA-162.88M-131.77M124%
Gain YTD-11.646-76.75415%
P/E RatioN/AN/A-
Revenue353M21.7M1,627%
Total Cash1.01B3.77M26,709%
Total Debt165M304M54%
FUNDAMENTALS RATINGS
BLUE: Fundamental Ratings
BLUE
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMBLUE
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 26 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BLUE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNSO17.270.45
+2.68%
MINISO Group Holding Limited
MCHX1.700.04
+2.41%
Marchex
DAC85.76-0.15
-0.17%
Danaos Corp
ALTI4.39-0.04
-0.90%
AlTi Global
ADI206.35-5.89
-2.78%
Analog Devices